Abstract |
Tissue transglutaminse-2 (TG2)-based immunoassays are the cornerstone of diagnosis in celiac disease (CeD), with a reported pooled sensitivity as high as 98%.1 However, a few small, single-center studies have questioned their sensitivity in clinical practice.2-5 Moreover, commercial kits use variable TG2 antigens,6 with cutoffs determined by using small, poorly defined populations. Variation in diagnostic performance of anti-TG2 assays in different racial and geographic populations has not yet been studied. We compared the interassay and intra-assay variations in diagnostic performance of 4 immunoglobulin (Ig)A-anti-TG2 assays in Canadian and Indian populations.
|
Authors | Prashant Singh, Alka Singh, Jocelyn A Silvester, Vikas Sachdeva, Xinhua Chen, Hua Xu, Daniel A Leffler, Vineet Ahuja, Donald R Duerksen, Ciaran P Kelly, Govind K Makharia |
Journal | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
(Clin Gastroenterol Hepatol)
Vol. 18
Issue 11
Pg. 2628-2630
(10 2020)
ISSN: 1542-7714 [Electronic] United States |
PMID | 31546060
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Autoantibodies
- Immunoglobulin A
- Transglutaminases
|
Topics |
- Autoantibodies
- Canada
- Celiac Disease
(diagnosis)
- Humans
- Immunoassay
- Immunoglobulin A
- Transglutaminases
|